SK-BR-3
Export
mammary gland, adenocarcinoma
Cell Type:
Mammary Epith.
Tissue Origin:
breast
Species:
human
Research Area:
Cancer Research/Cell Biology
Cell Characteristics:
Adherent
Transfection Information
Lonza Optimized Protocol
Optimization Guideline
Filter:
Any Substrate
Any Platform
The table below shows data for the cell type and Nucleofector™ Platform selected. Those data are either based on Lonza Optimized Protocols
or on results shared from customers who performed an optimization based on our guidelines. In case no data are shown for the selected Nucleofector™ Platform, please take a look at our
optimization strategy
to get further guidance on how to easily determine optimal Nucleofection conditions yourself.
Protocol
Kit
Program
Cells
Efficiency
Viable Cells
Substrate
Format
Platform
SF
EO-117
2e5
63-70%
60-70%
Plasmid (general)
0.8 µg
20 µl
4D X-Unit
SF
EO-117
1e6
60-70%
60-70%
Plasmid (general)
4 µg
100 µl
4D X-Unit
C
E-009
5e5
50%
90-95%
Plasmid (general)
2 µg
100 µl
I/II/2b
Citations
Role of Sox-9, ER81 and VE-cadherin in retinoic acid-mediated trans-differentiation of breast cancer cells
Categories:
Transfection
Authors:
Endo Y, Deonauth K, Prahalad P, Hoxter B, Zhu Y, Byers SW
In:
PLoS ONE (2008) 3(7): e2714
Growth factor-dependent regulation of survivin by c-myc in human breast cancer
Categories:
Transfection
Authors:
Cosgrave N, Hill AD, Young LS
In:
J Mol Endocrinol (2006) 37(3): 377-90
Nongenomic oestrogen signalling in oestrogen receptor negative breast cancer cells: a role for the angiotensin II receptor AT1
Categories:
Transfection
Authors:
Lim KT, Cosgrave N, Hill AD, Young LS
In:
Breast Cancer Res (2006) 8(3): R33